Literature DB >> 25964644

The need for United States-based guidelines for myeloproliferative neoplasms.

Brady L Stein, Susan O'Brien, Peter Greenberg, Ruben A Mesa.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25964644      PMCID： PMC8148874          DOI： 10.6004/jnccn.2015.0078

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  13 in total

Review 1.  Guideline for investigation and management of adults and children presenting with a thrombocytosis.

Authors:  Claire N Harrison; David Bareford; Nauman Butt; Peter Campbell; Eibhlean Conneally; Mark Drummond; Wendy Erber; Tamara Everington; Anthony R Green; Georgina W Hall; Beverley J Hunt; Christopher A Ludlam; Richard Murrin; Catherine Nelson-Piercy; Deepti H Radia; John T Reilly; Jon Van der Walt; Bridget Wilkins; Mary F McMullin
Journal:  Br J Haematol       Date:  2010-03-15       Impact factor: 6.998

2.  Amendment to the guideline for diagnosis and investigation of polycythaemia/erythrocytosis.

Authors:  Mary F McMullin; John T Reilly; Peter Campbell; David Bareford; Anthony R Green; Claire N Harrison; Eibhlin Conneally; Kate Ryan
Journal:  Br J Haematol       Date:  2007-08-02       Impact factor: 6.998

3.  Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project.

Authors:  Giovanni Barosi; Ruben Mesa; Guido Finazzi; Claire Harrison; Jean-Jacques Kiladjian; Eva Lengfelder; Mary F McMullin; Francesco Passamonti; Alessandro M Vannucchi; Carlos Besses; Heinz Gisslinger; Jan Samuelsson; Srdan Verstovsek; Ronald Hoffman; Animesh Pardanani; Francisco Cervantes; Ayalew Tefferi; Tiziano Barbui
Journal:  Blood       Date:  2013-04-16       Impact factor: 22.113

Review 4.  Molecular diagnosis of mast cell disorders: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology.

Authors:  Cem Akin
Journal:  J Mol Diagn       Date:  2006-09       Impact factor: 5.568

5.  Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet.

Authors:  Tiziano Barbui; Giovanni Barosi; Gunnar Birgegard; Francisco Cervantes; Guido Finazzi; Martin Griesshammer; Claire Harrison; Hans Carl Hasselbalch; Rudiger Hehlmann; Ronald Hoffman; Jean-Jacques Kiladjian; Nicolaus Kröger; Ruben Mesa; Mary F McMullin; Animesh Pardanani; Francesco Passamonti; Alessandro M Vannucchi; Andreas Reiter; Richard T Silver; Srdan Verstovsek; Ayalew Tefferi
Journal:  J Clin Oncol       Date:  2011-01-04       Impact factor: 44.544

6.  Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report.

Authors:  Ayalew Tefferi; Francisco Cervantes; Ruben Mesa; Francesco Passamonti; Srdan Verstovsek; Alessandro M Vannucchi; Jason Gotlib; Brigitte Dupriez; Animesh Pardanani; Claire Harrison; Ronald Hoffman; Heinz Gisslinger; Nicolaus Kröger; Juergen Thiele; Tiziano Barbui; Giovanni Barosi
Journal:  Blood       Date:  2013-07-09       Impact factor: 22.113

7.  Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.

Authors:  Rocco Piazza; Simona Valletta; Nils Winkelmann; Sara Redaelli; Roberta Spinelli; Alessandra Pirola; Laura Antolini; Luca Mologni; Carla Donadoni; Elli Papaemmanuil; Susanne Schnittger; Dong-Wook Kim; Jacqueline Boultwood; Fabio Rossi; Giuseppe Gaipa; Greta P De Martini; Paola Francia di Celle; Hyun Gyung Jang; Valeria Fantin; Graham R Bignell; Vera Magistroni; Torsten Haferlach; Enrico Maria Pogliani; Peter J Campbell; Andrew J Chase; William J Tapper; Nicholas C P Cross; Carlo Gambacorti-Passerini
Journal:  Nat Genet       Date:  2012-12-09       Impact factor: 38.330

8.  Chronic Myelogenous Leukemia, Version 1.2014.

Authors:  Susan O'Brien; Jerald P Radich; Camille N Abboud; Mojtaba Akhtari; Jessica K Altman; Ellin Berman; Daniel J DeAngelo; Michael Deininger; Steven Devine; Amir T Fathi; Jason Gotlib; Madan Jagasia; Patricia Kropf; Joseph O Moore; Arnel Pallera; Javier Pinilla-Ibarz; Vishnu Vb Reddy; Neil P Shah; B Douglas Smith; David S Snyder; Meir Wetzler; Kristina Gregory; Hema Sundar
Journal:  J Natl Compr Canc Netw       Date:  2013-11       Impact factor: 11.908

9.  Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations.

Authors:  Anthony J Bench; Helen E White; Letizia Foroni; Anna L Godfrey; Gareth Gerrard; Susanna Akiki; Abida Awan; Ian Carter; Andrea Goday-Fernandez; Stephen E Langabeer; Tim Clench; Jordan Clark; Paul A Evans; David Grimwade; Anna Schuh; Mary F McMullin; Anthony R Green; Claire N Harrison; Nicholas C P Cross
Journal:  Br J Haematol       Date:  2012-10-11       Impact factor: 6.998

10.  Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.

Authors:  Julia E Maxson; Jason Gotlib; Daniel A Pollyea; Angela G Fleischman; Anupriya Agarwal; Christopher A Eide; Daniel Bottomly; Beth Wilmot; Shannon K McWeeney; Cristina E Tognon; J Blake Pond; Robert H Collins; Basem Goueli; Stephen T Oh; Michael W Deininger; Bill H Chang; Marc M Loriaux; Brian J Druker; Jeffrey W Tyner
Journal:  N Engl J Med       Date:  2013-05-09       Impact factor: 91.245
View more
  1 in total

Review 1.  Ruxolitinib in Myelofibrosis and Polycythemia Vera.

Authors:  Leah Wolfe
Journal:  J Adv Pract Oncol       Date:  2016-05-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.